Additionally, they have found that repression of Axl expression could lead to inhibition of NF-κB signaling, induce GSK3β activity and block ESCC cell proliferation in an Axl-dependent manner [32]. The gene discussed is NFKB1; the disease is esophageal squamous cell carcinoma.